34 research outputs found
INTRODUCING NOVEL COMBINATORIAL TARGETED THERAPIES IN MULTIPLE TYPES OF CANCER
The cancers of liver, colon and breast are amongst the top five most prevalent and most fatal worldwide. As the Raf/MEK/ERK pathway is frequently deregulated in hepatocellular carcinoma (HCC), sorafenib, a Raf kinase inhibitor, became the first systemic therapy approved for the treatment of patients with HCC. However, sorafenib only produced modest effects with low response rates in the clinic. Similarly, regorafenib, which was approved for the treatment of metastatic colorectal cancer (CRC), has had a poor response rate in the clinic. Since phosphodiesterase type 5 has been reported to be overexpressed in HCC and CRC, we hypothesized that sildenafil, a phosphodiesterase type 5 inhibitor, could enhance the toxicities of sorafenib and regorafenib in HCC and CRC cells, respectively. Our in vitro data indicated that the drugs interacted strongly to kill cancer cells via induction of ER stress, autophagy and apoptosis. In accordance with these findings, our in vivo data demonstrated a significant reduction in tumor growth.
The second study in this manuscript was conducted based on the growing body of evidence about the significant contribution of EGFR and JAK/STAT signaling to the breast tumorigenesis. Our preliminary in vitro data demonstrated that the concurrent inhibition of these two pathways by lapatinib, a dual ERBB1/2 inhibitor, and ruxolitinib, a JAK1/2 inhibitor, synergistically killed breast cancer cells of all types, including the resistant triple negative subtype. Our mechanistic studies showed that the combination of ruxolitinib and lapatinib triggered cytotoxic mitophagy, and autophagy-dependent activation of BAX and BAK leading to the mitochondrial dysfunction
Lapatinib and Sorafenib Kill GBM Tumor Cells in a Greater than Additive Manner
Glioblastoma multiforme (GBM) is the most common and malignant brain tumor in adults, affecting thousands of people worldwide every year, with a life expectancy, post diagnosis of 12 months. Surgery, radiotherapy and chemotherapy together, result in an overall mean survival not exceeding 15 months. Targeted therapeutic agents sorafenib, an oral multi kinase inhibitor, and lapatinib, an epidermal growth factor receptor (EGFR) inhibitor, used in combination have been shown to kill GBM cells be through inhibition of major growth mediating signaling pathways that are frequently over expressed in gliomas, including mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase/ protein kinase B (PI3K/AKT). Sorafenib can restore lapatinib induced cytotoxicity by down regulation of myeloid cell leukaemia-1 (Mcl-1) expression. Prior studies have shown Mcl-1 to play an important role in resistance to lapatinib. Furthermore, data indicated that this drug combination is able to trigger activation of autophagic and apoptotic pathways and induce endoplasmic reticulum (ER) stress response in GBM cells, collectively resulting in cell death. In conclusion, data presented here demonstrates that the combination of sorafenib and lapatinib can kill GBM cells in a greater than additive fashion, through induction of autophagy, apoptotic events (extrinsic and intrinsic) and ER stress
Serum Hsp70 antigen: Early diagnosis marker in perinatal asphyxia
BACKGROUND:
Perinatal asphyxia is an important cause of mortality and permanent neurological and developmental deficit. Early and accurate diagnosis would help to establish the likely prognosis and may also help in determining the most appropriate treatment. Studies in experimental animal models suggest that a protein called Hsp70 may be a good and potentially useful marker of cellular stress that may be clinically useful in determining the presence of neonatal asphyxia.
OBJECTIVES:
Regarding the importance of early and accurate diagnosis of asphyxia, we conducted this study, which is the first investigation of the comparison of the serum Hsp70 antigen level between asphyxiated and healthy infants.
PATIENTS AND METHODS:
In this observational study, the serum concentrations of Hsp70 antigen were compared between neonates suffering from perinatal asphyxia (n = 50) and normal neonates (n = 51). The inclusion criteria for the cases were neonates who had reached term and had at least two clinical criteria of asphyxia. Exclusion criteria were babies with gestational age < 37 weeks, infants with congenital abnormalities or positive blood culture. Exclusion criteria in this group were the requirement to hospital stay during first week of the life or babies whose mothers had difficulties during pregnancy or delivery. Term neonates without major anomalies who had asphyxia during delivery were enrolled in the first six hours after delivery, and control group consisted of healthy term neonates without problems and normal delivery process in the first week of life. The cord blood was taken during labor to measure Hsp70 antigen level by using an in-house ELISA (The enzyme-linked immunosorbent assay).
RESULTS:
The median values of serum anti Hsp70 titers were significantly higher in asphyxiated neonates compared with non-asphyxiated neonates (0.36 [0.04 - 1.14] vs 0.24 [0.01 - 0.63]). At cutoff point = 0.3125 ng/mL, sensitivity was 58% and specificity 76% based on ROC curve.
CONCLUSIONS:
A significant difference between the serum concentrations of Hsp70 of the control and patient group was observed in this study. It is inferred serum concentrations of Hsp70 antigen may be a useful marker for the early diagnosis of that prenatal hypoxia
[Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling
In the completed phase I trial NCT01450384 combining the anti-folate pemetrexed and the multi-kinase inhibitor sorafenib it was observed that 20 of 33 patients had prolonged stable disease or tumor regression, with one complete response and multiple partial responses. The pre-clinical studies in this manuscript were designed to determine whether [pemetrexed + sorafenib] –induced cell killing could be rationally enhanced by additional signaling modulators. Multiplex assays performed on tumor material that survived and re-grew after [pemetrexed + sorafenib] exposure showed increased phosphorylation of ERBB1 and of NFκB and IκB; with reduced IκB and elevated G-CSF and KC protein levels. Inhibition of JAK1/2 downstream of the G-CSF/KC receptors did not enhance [pemetrexed + sorafenib] lethality whereas inhibition of ERBB1/2/4 using kinase inhibitory agents or siRNA knock down of ERBB1/2/3 strongly promoted killing. Inhibition of ERBB1/2/4 blocked [pemetrexed + sorafenib] stimulated NFκB activation and SOD2 expression; and expression of IκB S32A S36A significantly enhanced [pemetrexed + sorafenib] lethality. Sorafenib inhibited HSP90 and HSP70 chaperone ATPase activities and reduced the interactions of chaperones with clients including c-MYC, CDC37 and MCL-1. In vivo, a 5 day transient exposure of established mammary tumors to lapatinib or vandetanib significantly enhanced the anti-tumor effect of [pemetrexed + sorafenib], without any apparent normal tissue toxicities. Identical data to that in breast cancer were obtained in NSCLC tumors using the ERBB1/2/4 inhibitor afatinib. Our data argue that the combination of pemetrexed, sorafenib and an ERBB1/2/4 inhibitor should be explored in a new phase I trial in solid tumor patients
Hepcidin and HFE Polymorphisms and Ferritin Level in β-Thalassemia Major
Background: Thalassemia patients need repeated transfusion that lead to increased blood ferritin level and iron overload in the heart and liver. Because the roles of hepcidin antimicrobial peptide (HAMP) and hemocromatosis protein (HFE) in iron metabolism have been confirmed, this study investigated the effects of these gene's polymorphisms on blood ferritin levels and iron overload in the heart and liver in patients with beta thalassemia major Materials and Methods: This cross-sectional study was conducted on 91 patients referring to the Hajar Hospital in Shahrekord, Iran in 2015. After the blood samples were collected, the ferritin levels were measured, DNA was extracted from the blood cells, and the types of polymorphisms were determined using PCR-RFLP. Data of MRI T2* in the heart and liver were drawn from the patients' medical files. Data analysis was conducted by t-test, chi-square test, Fisher's exact test, and Pearson correlation coefficient. Results: There was no significant correlation between blood ferritin level and c.-582 A>G polymorphisms of hepcidin gene (p=0.58), and H63D of HFE gene (p=0.818). In addition, there was no significant association between the polymorphisms and heart and liver MRI, but there was a significant association between blood ferritin level and qualitative heart and liver MRI (r=-0.34, p=0.035 and r=-0.001, p=0.609, respectively). Conclusion: In patients with β-thalassemia major, the presence of c.-582A>G HAMP and H63D HFE polymorphisms is not effective on blood ferritin level and iron overload in the heart and liver in the studied region.
KEYWORDS:
Ferritin; HFE* Iron overload; Hepcidin; Thalassemi
The Impact of Climate & Weather upon Tourism with Particular emphasis on snow Skiing development in Iran
Tourist actrvrties are not distributed homogeneously in space; rather, certain activities are concentrated in specific points or areas. Numerous factors account for this pattern. Climate is one of the geophysical factors that make up geographical space, contributing to the environmental conditions that facilitate or hinder human settlement in general and tourism activities in particular. Therefore, climate is an important criterion for locating tourism centers, helping to determine how an area is to be used. It has been argued that local climatology and succession of different weather types influence the location of resorts, the calendar of tourist activities, the use and efficiency of the infrastructure, and the return on investments. The impact of climate ad well as climatic changes upon Snow skiing is being pursued as another objective of this study. As such, evaluation of Ski-resort potentials in Iran was conducted as an applied nature of this study. This study suggests that optimum areas regarding snow skiing are basically Elborz ranges between Tehran and Mazandran and to a lesser extent Charmahal province nested in Zagrous mountain
Microwave irradiation in solvent-free conditions: Preparation of 2-substituted 4(3<i>H</i>)-quinazolinones by heterocyclisation of 2- aminobenzamide with carboxylic acids
679-681A simple and
fast preparation of 2-substituted-4(3H)quinazolinones in high yields has been
developed by microwave induced heterocyclisation of 2-aminobenzamide with
carboxylic
acids in
solvent-free conditions. In comparison, the reactions are 40-80 times faster
under microwave irradiation and the yields are much higher than conventional
heating
The Effect of Physical Illnesses on the Deprivation of Child Custody
The ultimate goal of child custody is the realization of children's benefits and to keep them out of harm.Therefore, if the parents lack base qualifications and abilities, the child custody will be deprived of them. Also in the article 1173 of the Civil Code, child custody deprivation from its holder is considered. Since one of the qualifications of child's supervisor is his (her) physical health, this paper, by analysis of jurists' opinions, is going to examine the impact of illnesses on child custody. It further surveys that if the guardian has an infectious illness, endangering child's physical health, or he (she) is not able to keep the child due to an incurable disease, his (her) custody will be void. But if the guardian be able to prevent the spread of illness to the child or does the affairs resulting the maintenance and upbringing of the child through an agent for example, child custody will be constant according to the legal rule
Vailation of the Persian Version of the Staff Observation Aggression Scale-Revised in Psychiatric Patients
Introduction: In psychiatric settings, aggressive events frequently occur during therapy. These events, which tend to threaten the safety of the patient and the staff, can lead to the enforcement of compulsory measures such as the isolation or restraining of the patient. The use of a proper standard scale to register aggression can facilitate the assessment and control of aggression and help reduce its frequency and severity. The review of literature revealed only a few studies conducted on aggressive behavior in hospitalized psychiatric patients in Iran and showed that the lack of a reliable and valid observation scale for registering in psychiatric settings. The aim of this study is to evaluate the validity and reliability of the Staff Observation Aggression Scale—Revised (SOAS-R). Methods: This psychometric study of the scale was conducted to determine the validity and reliability of the SOAS-R. The validation of the scale was assessed on the basis of 319 aggressive events in the psychiatric wards of the Baqiyatallah and Roozbeh hospitals. Convenience sampling was used for subject selection. Psychometric properties of SOAS-R were studied in two stages. First, the standard scale was translated according to the International Quality of Life Assessment (IQOLA) translation methodology. The face validity, content , and construct validity of the translated version were then determined. The construct validity of the scale was assessed by comparing the known groups. Results: The internal consistency of the whole scale was 0.99. The intra-class correlation coefficients (ICC) were 0.852–0.995 while kappa coefficient was 0.43 to 0.65 for the different aspects of the SOAS-R. The validity of the scale was concurrently assessed by using the Visual Analogue Scale (VAS), with a Spearman-Brown correlation coefficient of 0.90. Conclusion: These results showed a favourable validity and reliability for the Persian version of the SOAS-R for the assessment of aggressive behaviour in psychiatric patients
Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function
We performed proteomic studies using the GRP78 chaperone-inhibitor drug AR-12 (OSU-03012) as bait. Multiple additional chaperone and chaperone-associated proteins were shown to interact with AR-12, including: GRP75, HSP75, BAG2; HSP27; ULK-1; and thioredoxin. AR-12 down-regulated in situ immuno-fluorescence detection of ATP binding chaperones using antibodies directed against the NH2-termini of the proteins but only weakly reduced detection using antibodies directed against the central and COOH portions of the proteins. Traditional SDS-PAGE and western blotting assessment methods did not exhibit any alterations in chaperone detection. AR-12 altered the sub-cellular distribution of chaperone proteins, abolishing their punctate speckled patterning concomitant with changes in protein co-localization. AR-12 inhibited chaperone ATPase activity, which was enhanced by sildenafil; inhibited chaperone - chaperone and chaperone - client interactions; and docked in silico with the ATPase domains of HSP90 and of HSP70. AR-12 combined with sildenafil in a GRP78 plus HSP27 -dependent fashion to profoundly activate an eIF2α/ATF4/CHOP/Beclin1 pathway in parallel with inactivating mTOR and increasing ATG13 phosphorylation, collectively resulting in formation of punctate toxic autophagosomes. Over-expression of [GRP78 and HSP27] prevented: AR-12 -induced activation of ER stress signaling and maintained mTOR activity; AR-12 -mediated down-regulation of thioredoxin, MCL-1 and c-FLIP-s; and preserved tumor cell viability. Thus the inhibition of chaperone protein functions by AR-12 and by multi-kinase inhibitors very likely explains why these agents have anti-tumor effects in multiple genetically diverse tumor cell types